Mid-term effects of laparoscopic sleeve gastrectomy on metabolic syndrome

Basit Öğe Kaydı
dc.authoridBurçin Batman / 0000-0003-2245-3337
dc.authorscopusidBurçin Batman / 43760983600
dc.authorscopusidHasan Altun / 55891276300
dc.authorwosidBurçin Batman / CDZ-5391-2022
dc.authorwosidHasan Altun / CEA-9796-2022
dc.contributor.authorBatman, Burçin
dc.contributor.authorAltun, Hasan
dc.date.accessioned2020-08-30T20:06:26Z
dc.date.available2020-08-30T20:06:26Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground: Obesity is associated with lower life expectancy and many comorbid diseases, including arterial hypertension, hyperlipidemia, and type 2 diabetes mellitus (T2DM), which is defined as metabolic syndrome (MetS). The aim of this study was to investigate the effects of laparoscopic sleeve gastrectomy (LSG) on parameters of MetS in obese patients 2 years after surgery. Methods: Between March 2013 and June 2019 1333 patients, who underwent LSG, were enrolled in this study; patients fulfilling the following conditions were considered eligible for LSG: body mass index (BMI) >= 40kg/m(2) or BMI >35kg/m(2) with comorbidities or BMI between 30 and 35kg/m(2) with T2DM or MetS. The patients were followed up by outpatient visits that were scheduled at 1st, 3rd, 6th, and 12th months postoperatively and annually thereafter. Results: One thousand three hundred and thirty-three patients underwent LSG. The mean age was 40.9310.86; 954 (71.5%) patients were female. After 2 years of surgery there was a significant improvement in glucose, glycosylated hemoglobin (HbA1c), insulin, the homeostasis model assessment insulin resistance, triglycerides, and high-density lipoprotein cholesterol (p<0.0001) with no significant reduction in serum total cholesterol (p=0.392) and low-density lipoprotein cholesterol (p=0.692) levels. Conclusions: LSG is an effective treatment for MetS and obesity related comorbidities.en_US
dc.identifier.citationBatman, B., & Altun, H. (2020). Mid-Term Effects of Laparoscopic Sleeve Gastrectomy on Metabolic Syndrome. Bariatric Surgical Practice and Patient Care, 15(1), 22-26.en_US
dc.identifier.doi10.1089/bari.2019.0052en_US
dc.identifier.endpage26en_US
dc.identifier.issn2168-023Xen_US
dc.identifier.issn2168-0248en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85082533442en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage22en_US
dc.identifier.urihttps://doi.org/10.1089/bari.2019.0052
dc.identifier.urihttps://hdl.handle.net/20.500.12713/517
dc.identifier.volume15en_US
dc.identifier.wosWOS:000497699200001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorBatman, Burçinen_US
dc.institutionauthorAltun, Hasanen_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofBariatric Surgical Practice and Patient Careen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSleeve Gastrectomyen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectBariatric Surgeryen_US
dc.subjectLipid Profileen_US
dc.titleMid-term effects of laparoscopic sleeve gastrectomy on metabolic syndromeen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
204.pdf
Boyut:
95.42 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Cerrahi Tıp Bilimleri Bölümü Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu